RAPT Therapeutics (RAPT) Other Accumulated Expenses (2020 - 2024)
Historic Other Accumulated Expenses for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $168000.0.
- Therapeutics' Other Accumulated Expenses rose 769.23% to $168000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $168000.0, marking a year-over-year increase of 769.23%. This contributed to the annual value of $178000.0 for FY2023, which is 2521.01% down from last year.
- According to the latest figures from Q3 2024, Therapeutics' Other Accumulated Expenses is $168000.0, which was up 769.23% from $126000.0 recorded in Q2 2024.
- In the past 5 years, Therapeutics' Other Accumulated Expenses ranged from a high of $436000.0 in Q1 2020 and a low of $117000.0 during Q1 2022
- In the last 5 years, Therapeutics' Other Accumulated Expenses had a median value of $236000.0 in 2023 and averaged $247684.2.
- Its Other Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 6538.46% in 2022, then skyrocketed by 10170.94% in 2023.
- Therapeutics' Other Accumulated Expenses (Quarter) stood at $328000.0 in 2020, then dropped by 22.56% to $254000.0 in 2021, then dropped by 6.3% to $238000.0 in 2022, then decreased by 25.21% to $178000.0 in 2023, then dropped by 5.62% to $168000.0 in 2024.
- Its last three reported values are $168000.0 in Q3 2024, $126000.0 for Q2 2024, and $203000.0 during Q1 2024.